Related by context. Frequent words. (Click for all words.) 71 HNSCC 70 biochemical recurrence 69 multivariate analyzes 69 pancreatic adenocarcinoma 68 locoregional 68 poor metabolizers 68 poorer prognosis 68 thyroid nodules 67 breast carcinoma 67 advanced adenomas 67 prognostic indicator 67 KRAS mutations 67 multivariate logistic regression 66 prognostic markers 66 carotid stenosis 66 estrogen receptor ER 66 lymph node involvement 66 KRAS mutation 66 platelet reactivity 65 resectable 65 lymph node metastasis 65 logistic regression analysis 65 QTc prolongation 65 prognostic significance 65 serum concentrations 65 etiologic 65 Baseline characteristics 65 MGUS 64 epithelial ovarian cancer 64 prognostic factors 64 endometrial cancers 64 colorectal carcinoma 64 prospectively defined 64 histologic 64 confidence interval #.#-#.# 64 liver transplant recipients 64 surrogate endpoint 64 tertile 64 distant metastasis 64 juvenile idiopathic arthritis 64 neoadjuvant therapy 64 T2DM 64 heavily pretreated 64 chemoradiotherapy 64 pheochromocytoma 64 posttreatment 63 genetic determinants 63 neurocognitive function 63 atherothrombosis 63 recurrent miscarriage 63 histopathological 63 GnRH agonists 63 neoadjuvant 63 hematologic toxicity 63 cervical intraepithelial neoplasia 63 subclinical hypothyroidism 63 HRQOL 63 sonographic findings 63 HER2 negative 63 thrombophilia 63 carcinoid 63 comorbid conditions 63 renal tumors 63 % CI #.#-#.# [003] 63 Pharmacokinetic 63 prognostic marker 63 ultrasonographic 63 decitabine 63 carcinoid tumors 62 EQ 5D 62 refractory chronic lymphocytic 62 extracranial 62 covariate 62 VKORC1 62 axillary lymph nodes 62 molecular biomarkers 62 GISTs 62 grade gliomas 62 HER2 positive metastatic breast 62 Secondary endpoints included 62 secondary hyperparathyroidism 62 intratumoral 62 rhGH 62 penetrance 62 PCa 62 histopathologic 62 lobular carcinoma 62 distant metastases 62 leukaemias 62 neoadjuvant chemotherapy 62 malignant pleural mesothelioma 62 laboratory abnormalities 62 prognostic factor 62 tibolone 62 teriflunomide 62 univariate 62 lipid lowering agents 62 Secondary endpoints include 62 univariate analysis 62 HSCT 62 MetS